CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 254 filers reported holding CANTEL MEDICAL CORP in Q4 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $783,000 | -80.0% | 9,860 | -80.2% | 0.00% | -85.7% |
| Q4 2020 | $3,913,000 | -25.5% | 49,764 | -58.4% | 0.01% | -22.2% |
| Q3 2020 | $5,251,000 | -15.1% | 119,495 | -16.6% | 0.01% | -10.0% |
| Q2 2020 | $6,185,000 | +553.1% | 143,199 | +443.0% | 0.01% | +400.0% |
| Q1 2020 | $947,000 | -26.5% | 26,370 | +36.9% | 0.00% | +100.0% |
| Q1 2019 | $1,288,000 | -78.0% | 19,257 | -75.5% | 0.00% | -85.7% |
| Q4 2018 | $5,855,000 | -61.6% | 78,647 | -52.5% | 0.01% | -53.3% |
| Q3 2018 | $15,240,000 | +224.5% | 165,541 | +246.6% | 0.02% | +200.0% |
| Q2 2018 | $4,697,000 | +83.0% | 47,756 | +107.3% | 0.01% | +66.7% |
| Q1 2018 | $2,566,000 | +512.4% | 23,033 | +466.1% | 0.00% | – |
| Q4 2017 | $419,000 | -34.5% | 4,069 | -40.1% | 0.00% | -100.0% |
| Q3 2017 | $640,000 | -27.3% | 6,797 | -39.8% | 0.00% | 0.0% |
| Q2 2017 | $880,000 | -47.3% | 11,294 | -45.8% | 0.00% | -50.0% |
| Q1 2017 | $1,670,000 | -39.4% | 20,854 | -40.4% | 0.00% | -50.0% |
| Q4 2016 | $2,757,000 | -15.5% | 35,009 | -16.3% | 0.00% | -20.0% |
| Q3 2016 | $3,261,000 | +46.2% | 41,821 | +28.9% | 0.01% | +25.0% |
| Q2 2016 | $2,230,000 | +38.1% | 32,443 | +43.4% | 0.00% | +33.3% |
| Q1 2016 | $1,615,000 | +14.5% | 22,628 | -0.3% | 0.00% | +50.0% |
| Q4 2015 | $1,411,000 | +9.5% | 22,700 | -0.1% | 0.00% | -33.3% |
| Q3 2015 | $1,288,000 | -5.1% | 22,724 | -10.2% | 0.00% | 0.0% |
| Q2 2015 | $1,357,000 | +17.8% | 25,293 | +4.3% | 0.00% | 0.0% |
| Q1 2015 | $1,152,000 | -21.5% | 24,243 | -28.6% | 0.00% | 0.0% |
| Q4 2014 | $1,468,000 | -22.4% | 33,934 | -38.4% | 0.00% | -40.0% |
| Q3 2014 | $1,892,000 | -20.9% | 55,043 | -15.7% | 0.01% | -16.7% |
| Q2 2014 | $2,391,000 | +9.9% | 65,293 | +1.2% | 0.01% | -14.3% |
| Q1 2014 | $2,175,000 | +0.1% | 64,493 | +0.6% | 0.01% | +16.7% |
| Q4 2013 | $2,173,000 | -1.2% | 64,093 | -7.2% | 0.01% | -25.0% |
| Q3 2013 | $2,199,000 | +23.1% | 69,043 | +30.9% | 0.01% | +33.3% |
| Q2 2013 | $1,786,000 | +110.6% | 52,729 | +84.8% | 0.01% | +50.0% |
| Q4 2012 | $848,000 | – | 28,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIKER MANAGEMENT LLC | 1,084,317 | $85,509,000 | 43.23% |
| Leonard Green & Partners, L.P. | 2,100,000 | $165,606,000 | 2.29% |
| Champlain Investment Partners, LLC | 3,952,620 | $311,704,000 | 1.79% |
| Brown Capital Management | 2,454,770 | $193,583,000 | 1.34% |
| Aurora Investment Counsel | 19,502 | $1,538,000 | 1.24% |
| Conestoga Capital Advisors, LLC | 797,481 | $62,889,000 | 1.00% |
| EMERALD ADVISERS, LLC | 292,554 | $23,071,000 | 0.77% |
| FRED ALGER MANAGEMENT, LLC | 3,470,340 | $273,671,000 | 0.71% |
| GENEVA CAPITAL MANAGEMENT LLC | 510,171 | $40,232,000 | 0.68% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 7,650 | $603,000 | 0.58% |